Legal & General Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.9M | Buy |
41,268
+689
| +2% | +$318K | ﹤0.01% | 844 |
|
|
2026
Q1 | $19.5M | Sell |
40,579
-3,503
| -8% | -$1.79M | ﹤0.01% | 827 |
|
|
2025
Q4 | $24.8M | Buy |
44,082
+2,065
| +5% | +$1.17M | 0.01% | 786 |
|
|
2025
Q3 | $21.6M | Sell |
42,017
-4,884
| -10% | -$2.13M | ﹤0.01% | 836 |
|
|
2025
Q2 | $14.7M | Sell |
46,901
-7,104
| -13% | -$2.13M | ﹤0.01% | 990 |
|
|
2025
Q1 | $16.5M | Buy |
54,005
+2,653
| +5% | +$892K | ﹤0.01% | 890 |
|
|
2024
Q4 | $17.1M | Sell |
51,352
-4,321
| -8% | -$1.47M | ﹤0.01% | 887 |
|
|
2024
Q3 | $18.6M | Buy |
55,673
+6,494
| +13% | +$2.47M | ﹤0.01% | 867 |
|
|
2024
Q2 | $20.3M | Sell |
49,179
-1,125
| -2% | -$446K | 0.01% | 831 |
|
|
2024
Q1 | $20.3M | Buy |
50,304
+812
| +2% | +$285K | 0.01% | 828 |
|
|
2023
Q4 | $15.2M | Sell |
49,492
-1,830
| -4% | -$494K | ﹤0.01% | 933 |
|
|
2023
Q3 | $12.4M | Sell |
51,322
-3,850
| -7% | -$985K | ﹤0.01% | 975 |
|
|
2023
Q2 | $13.3M | Buy |
55,172
+8,626
| +19% | +$1.79M | ﹤0.01% | 974 |
|
|
2023
Q1 | $8.75M | Sell |
46,546
-3,094
| -6% | -$640K | ﹤0.01% | 1119 |
|
|
2022
Q4 | $10.5M | Buy |
49,640
+1,786
| +4% | +$357K | ﹤0.01% | 1040 |
|
|
2022
Q3 | $7.52M | Sell |
47,854
-4,786
| -9% | -$764K | ﹤0.01% | 1163 |
|
|
2022
Q2 | $7.88M | Sell |
52,640
-1,604
| -3% | -$232K | ﹤0.01% | 1191 |
|
|
2022
Q1 | $8.87M | Buy |
54,244
+525
| +1% | +$86.6K | ﹤0.01% | 1219 |
|
|
2021
Q4 | $11.7M | Sell |
53,719
-1,040
| -2% | -$218K | ﹤0.01% | 1121 |
|
|
2021
Q3 | $10.4M | Buy |
54,759
+5,128
| +10% | +$935K | ﹤0.01% | 1158 |
|
|
2021
Q2 | $8.77M | Sell |
49,631
-8,518
| -15% | -$1.47M | ﹤0.01% | 1244 |
|
|
2021
Q1 | $9.54M | Buy |
58,149
+9,814
| +20% | +$1.5M | ﹤0.01% | 1234 |
|
|
2020
Q4 | $6.73M | Buy |
48,335
+5,580
| +13% | +$703K | ﹤0.01% | 1327 |
|
|
2020
Q3 | $4.78M | Sell |
42,755
-45,877
| -52% | -$5.3M | ﹤0.01% | 1348 |
|
|
2020
Q2 | $8.24M | Buy |
88,632
+7,440
| +9% | +$633K | ﹤0.01% | 1070 |
|
|
2020
Q1 | $5.97M | Buy |
81,192
+1,605
| +2% | +$139K | ﹤0.01% | 1078 |
|
|
2019
Q4 | $6.69M | Buy |
79,587
+8,382
| +12% | +$649K | ﹤0.01% | 1224 |
|
|
2019
Q3 | $5.98M | Buy |
71,205
+1,937
| +3% | +$146K | ﹤0.01% | 1206 |
|
|
2019
Q2 | $4.53M | Buy |
69,268
+1,490
| +2% | +$85.9K | ﹤0.01% | 1319 |
|
|
2019
Q1 | $4M | Buy |
67,778
+44,676
| +193% | +$2.67M | ﹤0.01% | 1340 |
|
|
2018
Q4 | $1.2M | Buy |
23,102
+19,666
| +572% | +$1.08M | ﹤0.01% | 1836 |
|
|
2018
Q3 | $206K | Buy |
3,436
+1,512
| +79% | +$82.7K | ﹤0.01% | 2322 |
|
|
2018
Q2 | $82K | Buy |
1,924
+321
| +20% | +$13K | ﹤0.01% | 2551 |
|
|
2018
Q1 | $56K | Sell |
1,603
-366
| -19% | -$13.4K | ﹤0.01% | 2698 |
|
|
2017
Q4 | $72K | Buy |
1,969
+114
| +6% | +$4K | ﹤0.01% | 2734 |
|
|
2017
Q3 | $59K | Hold |
1,855
| – | – | ﹤0.01% | 2864 |
|
|
2017
Q2 | $54K | Buy |
1,855
+620
| +50% | +$17.4K | ﹤0.01% | 2899 |
|
|
2017
Q1 | $35K | Sell |
1,235
-23
| -2% | -$742 | ﹤0.01% | 2940 |
|
|
2016
Q4 | $45K | Buy |
+1,258
| New | +$41.9K | ﹤0.01% | 2908 |
|
Other funds holding MEDP
WA
Legal & General Group's MEDP Position: Q2 2026 in Review
Legal & General Group increased its Medpace (MEDP) stake by 1.7% in Q2 2026, buying an estimated $318K and bringing the position to 41,268 shares worth $21.9M. The position accounts for ﹤0.01% of the portfolio, ranked #844.
Legal & General Group first reported a position in MEDP in Q4 2016 and has held it in 39 quarters since. The position peaked at $24.8M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Legal & General Group held 41,268 shares of Medpace worth $21.9M as of Q2 2026.
- Legal & General Group bought 689 Medpace shares in Q2 2026, an estimated $318K.
- Medpace made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #844 holding.
- Legal & General Group first reported a position in Medpace in Q4 2016 and has held it in 39 quarters since.
- Legal & General Group's Medpace position peaked at $24.8M in Q4 2025.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.